{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:08:46Z","timestamp":1792598926465,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministry of Science and Higher Education","award":["DS\/530-8457-D687-18"],"award-info":[{"award-number":["DS\/530-8457-D687-18"]}]},{"name":"Ministry of Science and Higher Education","award":["BMN 538-8457-B100-16"],"award-info":[{"award-number":["BMN 538-8457-B100-16"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jmgm.2019.05.009","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T11:30:54Z","timestamp":1557747054000},"page":"243-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cyclophosphamide and isophosphamide \u2013 DFT conformational studies in the gas phase and solution"],"prefix":"10.1016","volume":"90","author":[{"given":"Justyna","family":"Wieli\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Bednarko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henryk","family":"Myszka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Liberek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Nowacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2019.05.009_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ange.19580701705","article-title":"Synthese and Abbau cytostatisch wirksamer cyclischer N-Phosphamidester des Bis-(B-chlor\u00e4thyl)-amins","volume":"70","author":"Arnold","year":"1958","journal-title":"Angew. Chem."},{"key":"10.1016\/j.jmgm.2019.05.009_bib2","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jmgm.2019.05.009_bib3","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/cncr.22662","article-title":"Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia","volume":"109","author":"Shanafelt","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jmgm.2019.05.009_bib4","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1046\/j.1365-2133.2001.04191.x","article-title":"A\u00a0trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphoma","volume":"144","author":"Scarisbrick","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jmgm.2019.05.009_bib5","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/leu.2009.26","article-title":"Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial","volume":"23","author":"Reeder","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.jmgm.2019.05.009_bib6","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/1097-0142(19860815)58:4<832::AID-CNCR2820580404>3.0.CO;2-W","article-title":"Chemotherapy induces regression of brain metastases in breast carcinoma","volume":"58","author":"Rosner","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.jmgm.2019.05.009_bib7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/0959-8049(95)00068-T","article-title":"Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: preliminary results","volume":"31","author":"Donfrancesco","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jmgm.2019.05.009_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1200\/JCO.2007.12.1939","article-title":"Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, chicago, and princess margaret hospital phase II consortia","volume":"26","author":"Garcia","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.jmgm.2019.05.009_bib9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/0002-9394(86)90540-4","article-title":"Treatment of trilateral retinoblastoma with vincristine and cyclophosphamide","volume":"102","author":"Malik","year":"1986","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jmgm.2019.05.009_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/07391102.2011.10507382","volume":"29","author":"Omidvar","year":"2011","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2019.05.009_bib11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/jnci\/85.4.299","article-title":"The lung cancer study group, adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer","volume":"85","author":"Feld","year":"1993","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.jmgm.2019.05.009_bib12","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1200\/JCO.2008.16.5720","article-title":"Results of the EICESS-92 study: two randomized trials of ewing's sarcoma treatment\u2014cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients","volume":"26","author":"Paulussen","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.jmgm.2019.05.009_bib13","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1158\/1078-0432.CCR-05-2255","article-title":"Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors","volume":"12","author":"Young","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jmgm.2019.05.009_bib14","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1200\/JCO.2005.19.638","article-title":"Combination of Paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors","volume":"23","author":"Kondagunta","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.jmgm.2019.05.009_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V71.1.117.117","article-title":"Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)","volume":"71","author":"Velasquez","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.jmgm.2019.05.009_bib16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1191\/0961203304lu525oa","article-title":"Autologous stem cell transplantation for systemic lupus erythematosus","volume":"13","author":"Jayne","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.jmgm.2019.05.009_bib17","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/art.10495","article-title":"A\u00a0pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis","volume":"46","author":"Moore","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jmgm.2019.05.009_bib18","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1212\/WNL.0b013e3181a8164c","article-title":"Cyclophosphamide therapy in pediatric multiple sclerisis","volume":"72","author":"Makhani","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jmgm.2019.05.009_bib19","first-page":"1088","article-title":"J.\u00a0Samijn Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study","volume":"249","author":"Fassas","year":"2002","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.jmgm.2019.05.009_bib20","first-page":"29","article-title":"Preferred conformations of cyclophosphamide a theoretical study, pharma. And pharmacol","volume":"2","author":"Denny","year":"1996","journal-title":"Commun. Now."},{"key":"10.1016\/j.jmgm.2019.05.009_bib21","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1021\/ja00281a037","article-title":"Conformations of saturated six-membered-ring phosphorus heterocycles related to cyclophosphamide. NMR, x-ray, and infrared studies of 2-methoxy-2-oxo-1,3,2-oxazaphosphorinane and 2-thio-1,3,2-oxazaphosphorinane","volume":"108","author":"Bentrude","year":"1986","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2019.05.009_bib22","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1021\/ja00293a044","volume":"107","author":"Setzer","year":"1985","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2019.05.009_bib23","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1021\/ja00387a039","article-title":"Conformations of saturated six-membered ring phosphorus heterocycles. cis- and trans-2-oxo- and -2-thio-2-(dimethylamino)-5-tert-butyl-1,3,2\u03bb5-oxazaphosphorinanes: molecules related to cyclophosphamide","volume":"104","author":"Bajwa","year":"1982","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2019.05.009_bib24","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1016\/S0040-4020(01)89818-5","article-title":"Solution conformational analysis, crystal structure determination, and anticancer activity of ring-constrained 1,3,2-dioxa- and oxazaphosphorinane cyclophosphamide analogues","volume":"44","author":"Yang","year":"1988","journal-title":"Tetrahedron"},{"key":"10.1016\/j.jmgm.2019.05.009_bib25","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.5560\/znb.2012-0069","article-title":"DFT and MP2 study of the molecular structure and vibrational spectra of the anticancer agent cyclophosphamide","volume":"67b","author":"Badawi","year":"2012","journal-title":"Z.\u00a0Naturforsch."},{"key":"10.1016\/j.jmgm.2019.05.009_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1008193805436","article-title":"Molden: a pre- and post-processing program for molecular and electronic structures","volume":"14","author":"Schaftenaar","year":"2000","journal-title":"J.\u00a0Comput.-Aided Mol. Design"},{"key":"10.1016\/j.jmgm.2019.05.009_bib27","series-title":"Gaussian 09; Revision D.01","author":"Frisch","year":"2013"},{"key":"10.1016\/j.jmgm.2019.05.009_bib28","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density-functional thermochemistry. III. The role of exact exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.jmgm.2019.05.009_bib29","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","article-title":"Development of the Colle-Salvetti correlation energy formula into a functional of the electron density","volume":"37","author":"Lee","year":"1988","journal-title":"Phys. Rev. B"},{"key":"10.1016\/j.jmgm.2019.05.009_bib30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1021\/ct0502763","article-title":"Design of density functionals by combining the method of constraint satisfaction with parametrization for thermochemistry, thermochemical kinetics, and noncovalent interactions","volume":"2","author":"Zhao","year":"2006","journal-title":"J.\u00a0Chem. Theory Comput."},{"key":"10.1016\/j.jmgm.2019.05.009_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00214-007-0310-x","volume":"120","author":"Zhao","year":"2008","journal-title":"Theor. Chem. Acc"},{"key":"10.1016\/j.jmgm.2019.05.009_bib32","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1039\/b810189b","article-title":"Long-range corrected hybrid density functionals with damped atom-atom dispersion corrections","volume":"10","author":"Chai","year":"2008","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.jmgm.2019.05.009_bib33","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1021\/jp810292n","article-title":"Universal solvation model based on solute electron density and on a continuum model of the solvent defined by the bulk dielectric constant and atomic surface tensions","volume":"113","author":"Marenich","year":"2009","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.jmgm.2019.05.009_bib34","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1021\/jp809094y","article-title":"Performance of SM6, SM8, and SMD on the SAMPL1 test set for the prediction of small-molecule solvation free energies","volume":"113","author":"Marenich","year":"2009","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.jmgm.2019.05.009_bib35","unstructured":"E.D. Glendening, A. E. Reed, J. E. Carpenter, F. Weinhold, NBO Version 3.1."},{"key":"10.1016\/j.jmgm.2019.05.009_bib36","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1515\/znc-1977-9-1003","article-title":"X-ray-diffraction study and determination of absolute configuration of the anticancer drug S(\u2212)cyclophosphamide","volume":"32c","author":"Adamiak","year":"1977","journal-title":"Z.\u00a0Naturforsch."},{"key":"10.1016\/j.jmgm.2019.05.009_bib37","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1021\/cr00088a005","article-title":"Intermolecular interactions from a natural bond orbital, donor-acceptor viewpoint","volume":"88","author":"Reed","year":"1988","journal-title":"Chem. Rev."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326319301949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326319301949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:01:42Z","timestamp":1761080502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326319301949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":37,"alternative-id":["S1093326319301949"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2019.05.009","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclophosphamide and isophosphamide \u2013 DFT conformational studies in the gas phase and solution","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2019.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}